Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-061138
Filing Date
2010-06-25
Accepted
2010-06-25 15:42:52
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10-K c02831e10vk.htm 10-K 698627
2 EXHIBIT 14.1 c02831exv14w1.htm EX-14.1 35169
3 EXHIBIT 21 c02831exv21.htm EX-21 1792
4 EXHIBIT 31.1 c02831exv31w1.htm EX-31.1 5587
5 EXHIBIT 31.2 c02831exv31w2.htm EX-31.2 5567
6 EXHIBIT 32.1 c02831exv32w1.htm EX-32.1 2345
7 EXHIBIT 32.2 c02831exv32w2.htm EX-32.2 2361
8 GRAPHIC c02831c02831z0001.gif GRAPHIC 22034
  Complete submission text file 0000950123-10-061138.txt   783550
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-52530 | Film No.: 10917575
SIC: 2836 Biological Products, (No Diagnostic Substances)